Momenta fails to block competition to its generic blood thinner

Another effort on the part of Momenta Pharmaceuticals Inc. to stave off competition from another generic version of the blood-thinning drug, Lovenox, has failed...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.